Invention Grant
- Patent Title: Lipidated immune response modifier compound compositions, formulations, and methods
-
Application No.: US15822556Application Date: 2017-11-27
-
Publication No.: US10052380B2Publication Date: 2018-08-21
- Inventor: Paul D. Wightman
- Applicant: 3M Innovative Properties Company
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K39/39 ; A61K39/145 ; C12N7/00 ; A61K31/437 ; C07D471/04 ; A61K47/26 ; A61K39/00 ; A61K31/47 ; A61K9/10 ; A61K9/00
Abstract:
The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a vaccine adjuvant and a cancer treatment.
Public/Granted literature
- US20180200364A1 LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS Public/Granted day:2018-07-19
Information query
